KAPA · Forms 3, 4, 5
Insider trades at Kairos Pharma, LTD.
No open-market insider buys or sells at Kairos Pharma, LTD. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Kairos Pharma, LTD. (KAPA) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Kairos Pharma, LTD. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Neil Bhowmick | Chief Scientific Officer | Award | 171,756 | Form 4 | |||
| Hyun W. Bae | Director | Award | 19,084 | Form 4 | |||
| Ramachandran Murali | VP of Research and Development | Award | 152,672 | Form 4 | |||
| Hansoo Michael Keyoung | Director | Award | 19,084 | Form 4 | |||
| Rahul Singhvi | Director | Award | 19,084 | Form 4 | |||
| Doug Samuelson | Chief Financial Officer | Award | 152,672 | Form 4 | |||
| John S Yu | CEO and Chairman | Award | 190,840 | Form 4 | |||
| Hyun W. Bae | Director | Award | 10,000 | Form 4 | |||
| Hansoo Michael Keyoung | Director | Award | 10,000 | Form 4 | |||
| Rahul Singhvi | Director | Became an insider (Form 3) | Form 3 | ||||
| Neil Bhowmick | Chief Scientific Officer | Award | 14,000 | Form 4 | |||
| Ramachandran Murali | VP of Research and Development | Award | 14,000 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.